Hologic Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
417 / 663
Position in country
10006 / 14179
Return on Assets, %
5.6
-11.9
Net income margin, %
24.3
-12.5
EBITDA margin, %
31.1
-2.5
Debt to Equity, %
55.3
15
Intangible assets and goodwill, %
48.8
3.9
Revenue CAGR 3Y, %
2.1
12.6
Total Equity change 1Y, %
-8.7
0
Revenue Y, % chg
-11.2
4.6
P/E
36.7
28.3
P/BV
3.8
1.7
P/S
4.5
3.7
EV/S
4.7
3.2
EV/EBITDA
15.2
-0.2
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
9.9
66.5
Forward P/E
18.3
19.2
Expected dividend per share
0
0
Payout Ratio, %
0
17.3
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Hologic Inc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
18151.7
Ticker
HOLX.O
ISIN
US4364401012
IPO date
1990-03-01
Availability on Russian exchanges
Yes
Reporting for
2024-02-02
Date fact. publication of reports
2023-12-30
Company Description
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: